- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07418905
Technology-supported Motor Rehabilitation for People With Rett Syndrome (TeMoRett)
Technology-supported Motor Rehabilitation for People With Rett Syndrome (TeMoRett) Sub-project: Psychophysiological Personalization of the Technology-supported Motor Rehabilitation for People With Rett Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Baseline measurements taken at start of study. Training occurs for separation tasks for the first 13 weeks, with four 15-min sessions running per week. To gradually improve in ability to control gaming with arms/hands, each participant has the option of trying 13 levels or challenges on the extent of separation (how far apart hands can be taken.) Training occurs for the final 13 weeks for reaching tasks. Here, the participant must separate hands and reach for a defined target in order to initiate game play. These sessions will also last 15 minutes each and four sessions will be required per week.
At the conclusion of the 26 weeks of training, the measurements of functional arm/hand use, and other behavioral measurements taken at Baseline will be repeated and compared to Baseline to assist in determining the success of the gaming used to train purposeful and functional arm use.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20814
- Georgetown University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- dx of Rett syndrome
- functional range of motion of both arms
- no seizures or seizures managed with medication
- understanding cause and effect
- midline stereotypies
Exclusion Criteria:
- no competing orthopedic or neuromuscular diagnosis that impacts shoulder movements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gaming system
The study will involve several sequential phases: pre-intervention testing, cause-and-effect training/intervention, and a post-intervention testing phase.
The aim is to learn to control stereotypies and learn to interact with their environment to increase independent play skills.
Training will take place using telemedicine methods.
The game consists of computer generated games developed by the researchers specifically for the needs of individuals with dyspraxia.
The images or video that the participant will watch will be projected to the table.
The participant's hand movements to stop their stereotypies will be detected as the Start signal for the game to begin.
When hands return to their stereotypy, the computer camera will detect that as the Stop signal and the game will pause until hands are detected separated from each other again.
|
Investigators will personalize gaming sessions based on the motivators and interests of each participant.
During each intervention session, the participant will be encouraged to initiate voluntary hand separations in order to activate or control the gaming activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Counts and timing of obligatory stereotypies
Time Frame: 60 min functional assessment periods: one just before start of intervention (baseline) and one at the end of intervention (post-intervention testing) Weekly data collection from intervention sessions: enrollment to end of intervention 26 weeks later.
|
We will collect two variables: the number of times the participant engages in her unique stereotypy and the length of time (in seconds) that the stereotypy occurs.
Data will be collected from both weekly intervention sessions and the two functional assessments.
Functional data will be collected from the movements made by the individual as well as from BEFORE and AFTER questionnaires to be completed by the caregivers of the participant.
|
60 min functional assessment periods: one just before start of intervention (baseline) and one at the end of intervention (post-intervention testing) Weekly data collection from intervention sessions: enrollment to end of intervention 26 weeks later.
|
|
Timing and number of separations (ceasing stereotypies)
Time Frame: Two 60 minute assessment periods: one just before start of intervention (baseline) and one at the end of intervention (post-intervention testing). Data from intervention sessions will run from enrollment to end of intervention 26 weeks later.
|
Data will be collected from intervention sessions and the two functional assessments.
Data will be in both the number of times each girls separates hands (counts) and timing (in seconds) to record how long hands remained apart.
Functional data will be collected from the movements made by the individual as well as from BEFORE and AFTER questionnaires to be completed by the caregivers of the participant.
|
Two 60 minute assessment periods: one just before start of intervention (baseline) and one at the end of intervention (post-intervention testing). Data from intervention sessions will run from enrollment to end of intervention 26 weeks later.
|
|
Reaching data for number of reaches and amount of time reaching occurs
Time Frame: Two 60-minute assessment periods: one at baseline and one post final intervention session. Data from weekly intervention will be gathered from enrollment to 26 weeks later when intervention is complete.
|
Data will be collected from intervention sessions and the two functional reach assessments.
Counts of the number of purposeful reaches and the extent of time (measured in seconds) the reach is maintained.
Functional data will be collected from the movements made by the individual as well as from BEFORE and AFTER questionnaires to be completed by the caregivers of the participant.
|
Two 60-minute assessment periods: one at baseline and one post final intervention session. Data from weekly intervention will be gathered from enrollment to 26 weeks later when intervention is complete.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pamela Diener, PhD,MS,OT/L, Georgetown University
Publications and helpful links
General Publications
- McAmis NE, Foreman MH, Himmelrich MD, Diener PS and Engsberg JR. Development of a Method to Use a Color Tracker for Motor Therapy for Individuals with Rett Syndrome. SM J Pediatr. 2017; 2(2): 1012.
- Mraz KM, Amadio G, Diener P, Eisenberg G, Engsberg JR. Improving upper extremity motor skills in girls with rett syndrome using virtual reality. J of Intellect Disabil - Diagnosis and Treatment, 2016, 4(3):142-151.
- Mraz, K, Eisenberg G, Diener P, Amadio G, Foreman MH, Engsberg JR. The Effects of Virtual Reality on the Upper Extremity Skills of Girls with Rett Syndrome: A Single Case Study. J of Intellect Disabil- Diagnosis and Treatment. 2016, 4(3):152-9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Genetic Diseases, Inborn
- Neurobehavioral Manifestations
- Heredodegenerative Disorders, Nervous System
- Intellectual Disability
- Genetic Diseases, X-Linked
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- X-Linked Intellectual Disability
- Rett Syndrome
Other Study ID Numbers
- 13GW0488B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rett Syndrome
-
University of Alabama at BirminghamUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of... and other collaboratorsCompletedRett Syndrome, Preserved Speech Variant | Mecp2 Duplication Syndrome | Rett-related DisordersUnited States
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS); Vanderbilt...RecruitingRett Syndrome | Rett Syndrome, Atypical | RTTUnited States
-
Fenix Innovation GroupNeurotech International LimitedNot yet recruitingRett Syndrome | RETT Syndrome With Proven MECP2 MutationAustralia
-
Genecombio Ltd.Xinhua Hospital, Shanghai Jiao Tong University School of MedicineEnrolling by invitationRETT Syndrome with Proven MECP2 MutationChina
-
University of Alabama at BirminghamUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of... and other collaboratorsCompletedRett Syndrome | MECP2 Duplication Disorder | Rett-related DisorderUnited States
-
International Rett Syndrome FoundationBaylor College of Medicine; Children's Hospital of Philadelphia; University of... and other collaboratorsRecruitingNervous System Diseases | Neurologic Manifestations | Neurobehavioral Manifestations | Genetic Diseases, X-Linked | Intellectual Disability | Neurodevelopmental Disorders | Neurologic Disorder | Rett Syndrome | Genetic Disease | Rett Syndrome, AtypicalUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
University of TriestePoliclinico G . Martino, Messina Italy; IRCSS Gianna Gaslini, Genova, Italy; Policlinico... and other collaboratorsRecruiting
-
Unravel Biosciences, Inc.Recruiting
-
University Hospital, Basel, SwitzerlandNovartisCompletedRett's SyndromeSwitzerland
Clinical Trials on computer gaming
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada
-
University of ManitobaUnknownStroke | HemiplegiaCanada
-
Katrine SværkeUniversity of CopenhagenCompletedAcquired Brain Injury | Executive Dysfunction | Cognitive SymptomDenmark
-
University of ManitobaCanadian Arthritis NetworkCompletedRheumatoid Arthritis | Osteoarthritis of HandsCanada
-
Universitaire Ziekenhuizen KU LeuvenVrije Universiteit Brussel; Fund for Scientific Research, Flanders, BelgiumCompletedCerebral Visual ImpairmentBelgium
-
Children's Hospital of Eastern OntarioCanadian Institutes of Health Research (CIHR)CompletedActive Video Games and Appetite ControlCanada
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of British ColumbiaTerminatedStroke | Stroke, Ischemic | Stroke Hemorrhagic | Stroke, LacunarCanada
-
Cairo UniversityRecruiting
-
New York Institute of TechnologyCompletedCognitive Performance in Healthy VolunteersUnited States